603718 logo

Shanghai Hile Bio-Technology Co., Ltd. Stock Price

SHSE:603718 Community·CN¥3.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

603718 Share Price Performance

CN¥4.86
-2.21 (-31.26%)
CN¥4.86
-2.21 (-31.26%)
Price CN¥4.86

603718 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record.

1 Risk
2 Rewards

Shanghai Hile Bio-Technology Co., Ltd. Key Details

CN¥246.4m

Revenue

CN¥60.3m

Cost of Revenue

CN¥186.0m

Gross Profit

CN¥14.7m

Other Expenses

CN¥171.3m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 30, 2026
0.26
75.51%
69.55%
0.2%
View Full Analysis

About 603718

Founded
1981
Employees
366
CEO
Benyi Han
WebsiteView website
www.hile-bio.com

Shanghai Hile Bio-Technology Co., Ltd. develops, manufactures, and sells in vitro diagnostic reagents and oral tissue repair and regeneration materials in China. It operates through two segments: In Vitro Diagnostic Reagents and Oral Tissue Repair and Regeneration Materials. The In Vitro Diagnostic Reagents segment offers biochemical diagnostic reagents, immuno-latex reagents, immune turbidimetry reagents, latex enhanced immune turbidimetry reagents, enzyme-linked immunosorbent products, and related diagnostic kits, including matrix metalloproteinase 3, IV collagen, adiponectin, creatine kinase isoenzyme, hepatic bile acid, cardiac troponin I, heparin binding protein, hemoglobin A1C, lipoprotein phospholipase A2, heart fatty acid binding protein, ferritin, sialoglycoside antigen, and procalcitonin kits. The Oral Tissue Repair and Regeneration Materials segment provides oral bone repair materials, implant systems, natural bone repair materials, oral restorative films, collagen-based bone repair matrices, and soft tissue repair matrices, primarily for dental implantation and maxillofacial bone defect repair. The company was founded in 1981 and is headquartered in Shanghai, China.

Recent 603718 News & Updates

Recent updates

No updates